WA
OACCU

Whitebox Advisors’s Oaktree Acquisition Corp III Life Sciences Unit OACCU Stock Holding History

Whitebox Advisors’s Portfolio OACCU Stock Details OACCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-250,000
Closed -$2.61M – 408
2025
Q1 		$2.61M Hold
250,000
– – 0.07% 150
2024
Q4 		$2.53M Buy
+250,000
New +$2.52M 0.07% 120

Other funds holding OACCU

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Whitebox Advisors's OACCU Position: Q2 2025 in Review

Whitebox Advisors sold out of Oaktree Acquisition Corp III Life Sciences Unit (OACCU) in Q2 2025, closing a stake of 250,000 shares — an estimated $2.61M sold.

Whitebox Advisors first reported a position in OACCU in Q4 2024 and held it in 2 quarters. The position peaked at $2.61M in Q1 2025. 6 funds tracked by Wall St. Rank hold OACCU as of Q2 2025.

  • Whitebox Advisors reported no remaining Oaktree Acquisition Corp III Life Sciences Unit position as of Q2 2025 after selling out during the quarter.
  • Whitebox Advisors sold 250,000 Oaktree Acquisition Corp III Life Sciences Unit shares in Q2 2025, an estimated $2.61M.
  • Whitebox Advisors first reported a position in Oaktree Acquisition Corp III Life Sciences Unit in Q4 2024 and held it in 2 quarters.
  • Whitebox Advisors's Oaktree Acquisition Corp III Life Sciences Unit position peaked at $2.61M in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Unit as of Q2 2025.

Based on Whitebox Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.